Consumer Health in Finland
CONSUMER HEALTH IN FINLAND
Euromonitor International
January 2019
LIST OF CONTENTS AND TABLES
Executive Summary
Health and Wellness Trend and Stressful Lifestyles Drive Consumer Health Sales
the Improving Economy Boosts 2018 Value Sales As Innovative Products Emerge, While Counterbalanced by Intensifying Competition
Consumer Health Remains Fragmented and Players Present Across All Categories Are Rare
Consumer Health Products Are Sold Increasingly Online and in the Grocery Channel
Growth Rates Will Remain Positive, But Slowed Down by Competition and the Maturity of Some Large Categories
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 2 Life Expectancy at Birth 2013-2018
Market Data
Table 3 Sales of Consumer Health by Category: Value 2013-2018
Table 4 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 5 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 6 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 8 Distribution of Consumer Health by Format: % Value 2013-2018
Table 9 Distribution of Consumer Health by Format and Category: % Value 2018
Table 10 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Sources
Summary 2 Research Sources
Headlines
Prospects
Discussion of Liberalising Analgesics To New Channels Continues
Added-value Formats and Features Counterbalance the Lowering Effect of Generics
Switched Naproxen and Triptans Likely To Remain Niche Categories
Competitive Landscape
Local Orion Maintains Its Lead Amid Intensifying Competition
Gsk Consumer Healthcare Increases Its Share by Extending Its Portfolio
Lower-cost Vitabalans Oy Actively Develops Its Portfolio
Category Data
Table 12 Sales of Analgesics by Category: Value 2013-2018
Table 13 Sales of Analgesics by Category: % Value Growth 2013-2018
Table 14 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018
Table 15 NBO Company Shares of Analgesics: % Value 2014-2018
Table 16 LBN Brand Shares of Analgesics: % Value 2015-2018
Table 17 Forecast Sales of Analgesics by Category: Value 2018-2023
Table 18 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023
Headlines
Prospects
Convenience Supports Sales of Nasal Sprays, the Highest Growth Area
Grocery Channel Takes A Large Share of Sales
Several Areas Offer Opportunities for Innovative Products
Competitive Landscape
Orion Leads Fragmented Cough, Cold and Allergy (hay Fever) Remedies
Pgt Healthcare's Position Improves
Medicated Confectionery Brands Lead
Category Data
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018
Table 21 Sales of Decongestants by Category: Value 2013-2018
Table 22 Sales of Decongestants by Category: % Value Growth 2013-2018
Table 23 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018
Table 24 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018
Table 25 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 26 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023
Headlines
Prospects
Innovative Launches in Antifungals Keep Lifting Value
Growth of Other Dermatologicals Is Limited by the Increased Number of Generics
Systemic Variants Pose A Threat To the Growth of Cold Sore Treatments
Competitive Landscape
Orion Leads Dermatologicals, But With A Reduced Share
Third-placed Bayer Doubles Its Value Share Over the Review Period
Generics Manufacturers Orifarm and Paranova Set To Gain Share
Category Data
Table 27 Sales of Dermatologicals by Category: Value 2013-2018
Table 28 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 29 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 30 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 31 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018
Table 32 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 33 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023
Headlines
Prospects
Hectic Lifestyles and Imbalanced Diets Increase Demand for Digestive Remedies
Digestive Enzymes Benefits From Broad Channel Presence
Laxatives and Diarrhoeal Remedies Remain the Largest Sales Generators
Competitive Landscape
Takeda and Janssen-cilag Lead Digestive Remedies Thanks To Extensive Portfolios
Pgt Healthcare and Bayer Have Strong Positions in Indigestion and Heartburn Remedies
Generics and Private Label Slowly Emerge
Category Data
Table 34 Sales of Digestive Remedies by Category: Value 2013-2018
Table 35 Sales of Digestive Remedies by Category: % Value Growth 2013-2018
Table 36 NBO Company Shares of Digestive Remedies: % Value 2014-2018
Table 37 LBN Brand Shares of Digestive Remedies: % Value 2015-2018
Table 38 Forecast Sales of Digestive Remedies by Category: Value 2018-2023
Table 39 Forecast Sales of Digestive Remedies by Category: % Value Growth 2018-2023
Headlines
Prospects
Standard Eye Care Sales Remain Positive As Finns Spend More Time in Front of Screens
Cross-category Brands Likely To Become More Common
Ointments and Other Standard Eye Care Increase Their Share of Formats
Competitive Landscape
Thanks To A Broad Product Portfolio Santen Leads Eye Care Sales
Orion and Bayer Increase Their Value Shares
Eye Care Is Little Affected by Generics Or Private Label
Category Data
Table 40 Sales of Eye Care by Category: Value 2013-2018
Table 41 Sales of Eye Care by Category: % Value Growth 2013-2018
Table 42 Sales of Standard Eye Care by Format: % Value 2013-2018
Table 43 Sales of Standard Eye Care by Positioning: % Value 2013-2018
Table 44 NBO Company Shares of Eye Care: % Value 2014-2018
Table 45 LBN Brand Shares of Eye Care: % Value 2015-2018
Table 46 Forecast Sales of Eye Care by Category: Value 2018-2023
Table 47 Forecast Sales of Eye Care by Category: % Value Growth 2018-2023
Headlines
Prospects
Nrt Smoking Cessation Aids Remain High in Demand As Negative Sentiment Towards Smoking Strengthens
the Selection of Nrt Smoking Cessation Aids Continues To Swell
the Sales Role of the Pharmacy Channel Shrinks Further
Competitive Landscape
Nicorette and Nicotinell Continue To Dominate, But With Reduced Shares
New Company Entries Challenge the Leading Players
Increased Competition May Affect Unit Prices Negatively
Category Indicators
Table 48 Number of Smokers by Gender 2013-2018
Category Data
Table 49 Sales of NRT Smoking Cessation Aids by Category: Value 2013-2018
Table 50 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2013-2018
Table 51 Sales of NRT Gum by Flavour: % Value 2013-2018
Table 52 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2014-2018
Table 53 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2015-2018
Table 54 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2018-2023
Table 55 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2018-2023
Headlines
Prospects
Minerals and Fish Oils Suffer From Maturity, But Value Can Still Be Added
Well-positioned Targeting of Combination Supplements Is Vital
Natural/herbal Supplements Expected To Do Well
Competitive Landscape
Brand Strategy Is Important in Fractured Dietary Supplements
All Top Players in Dietary Supplements Are Local
Increased Sales in Grocery Retailing Lift the Share of Private Label and Lower-priced Brands
Category Data
Table 56 Sales of Dietary Supplements by Category: Value 2013-2018
Table 57 Sales of Dietary Supplements by Category: % Value Growth 2013-2018
Table 58 Sales of Dietary Supplements by Positioning: % Value 2013-2018
Table 59 Sales of Fish Oils/Omega Fatty Acids by Type: % Value 2013-2018
Table 60 NBO Company Shares of Dietary Supplements: % Value 2014-2018
Table 61 LBN Brand Shares of Dietary Supplements: % Value 2015-2018
Table 62 Forecast Sales of Dietary Supplements by Category: Value 2018-2023
Table 63 Forecast Sales of Dietary Supplements by Category: % Value Growth 2018-2023
Headlines
Prospects
Cleaner and More Natural Alternatives Are in Demand But Need Careful Positioning
Fashionable Superfoods and Biohacking Are Emerging Trends That May Take Off in the Forecast Period
Herbal Tonics Set To Be Among the Best-performing Categories in the Forecast Period
Competitive Landscape
Two of the Top Three Brands Are Medicated Confectionery
Finnish Valioravinto and Hankintatukku Arno Latvus Have Strong and Stable Positions
Well-branded New Ranges Slowly Increase Their Sales and Have Potential in the Forecast Period
Category Data
Table 64 Sales of Herbal/Traditional Products by Category: Value 2013-2018
Table 65 Sales of Herbal/Traditional Products by Category: % Value Growth 2013-2018
Table 66 NBO Company Shares of Herbal/Traditional Products: % Value 2014-2018
Table 67 LBN Brand Shares of Herbal/Traditional Products: % Value 2015-2018
Table 68 Forecast Sales of Herbal/Traditional Products by Category: Value 2018-2023
Table 69 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2018-2023
Headlines
Prospects
Paediatric Analgesics Set To See Healthy Growth in the Forecast Period Thanks To Paediatric Ibuprofen Launches
Paediatric Vitamins and Dietary Supplements Needs More Targeted Launches
Convenience and Easy-to-use Features Are Highly Important in Paediatric Consumer Health
Competitive Landscape
Gsk Consumer Healthcare Leads Thanks To Its Strong Position in Paediatric Analgesics
Second-placed Orion Has An Extended Product Portfolio
Local Verman and Vitabalans Improve Their Rankings
Category Data
Table 70 Sales of Paediatric Consumer Health by Category: Value 2013-2018
Table 71 Sales of Paediatric Consumer Health by Category: % Value Growth 2013-2018
Table 72 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2018
Table 73 NBO Company Shares of Paediatric Consumer Health: % Value 2014-2018
Table 74 LBN Brand Shares of Paediatric Consumer Health: % Value 2015-2018
Table 75 Forecast Sales of Paediatric Consumer Health by Category: Value 2018-2023
Table 76 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023
Contradictorily, while an increased number of Finns have actively looked for ways to improve their health and wellbeing, a higher share of the population have suffered from health issues, often due to stressful lifestyles and a poor work-life balance. This was seen clearly in the consumption of consumer health products in Finland during the review period. Sales of products such as sports nutrition and preventive dietary supplements have soared, and products such as sleep aids, stress relief supp...
Euromonitor International's Consumer Health in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.